Proscia raised $50 million in Series C funding to develop its AI pathology platform aimed at enhancing precision diagnostics. The initiative targets healthcare organizations demanding advanced diagnostic solutions, integrating machine learning techniques for image analysis and diagnostics clarity in medical fields. The investment signifies growth in healthtech AI applications.
🚀 Proscia Secures $50M for AI Pathology Expansion
